Ibrexafungerp
Ibrexafungerp is an orally bioavailable antifungal agent that inhibits β-1,3-glucan synthase, compromising fungal cell wall integrity. It is used in research for studying invasive fungal infections, demonstrating activity in both in vitro assays and in vivo animal models.
Product Specifications
CAS Number
1207753-03-4
Product Name Alternative
SCY 078, SCY078, SCY-078, MK 3118, MK3118, MK-3118, GSK 5458448, GSK5458448
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
99.65% (May vary between batches)
Smiles
C[C@@]12[C@]3 ([C@@] (C=4[C@@] ([C@]5 (C) [C@@] (C) (CC4) [C@H] (C (O) =O) [C@] ([C@@H] (C (C) C) C) (C) CC5) (CC3) [H]) (C[C@H] ([C@@H]1OC[C@] ([C@@] (C) (C) C) (C) N) N6C (=NC=N6) C=7C=CN=CC7) COC2) [H]
Molecular Formula
C44H67N5O4
Molecular Weight
730.03
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog